IDYA - IDEAYA Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$56.33
DETAILS
HIGH:
$63.00
LOW:
$48.00
MEDIAN:
$58.00
CONSENSUS:
$56.33
UPSIDE:
55.78%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 97.9% |
| EBIT Margin | -52.0% |
| EBITDA Margin | -49.9% |
| Operating Margin | -72.8% |
| Pretax Margin | -52.0% |
| Cont. Ops Margin | -52.0% |
| Net Margin | -52.0% |
| Bottom Line Margin | -52.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 11.34 |
| Quick Ratio | 11.34 |
| Solvency Ratio | -1.263 |
| Cash Ratio | 1.92 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-27.01
Peers avg: 8.6
|
| PEG Ratio | 0.44 |
| Forward PEG | 0.44 |
| Price/Book | 2.99 |
| Price/Sales | 13.99 |
| Price/FCF | -41.64 |
| Price/Op Cash Flow | -43.02 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0252 |
| Debt/Equity | 0.0273 |
| Debt/Capital | 0.0266 |
| Long-Term Debt/Capital | 0.0262 |
| Financial Leverage | 1.08 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.35 |
| Operating Cash Flow Ratio | -1.209 |
| Operating Cash Flow/Sales | -32.5% |
| Free Cash Flow/Operating Cash Flow | 103.3% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -321.84 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -209.73 |
| Operating Cash Flow Coverage | -2.55 |
| Capital Expenditure Coverage | -30.02 |
| Dividend + Capital Expenditure Coverage | -30.02 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 2.47 |
| EPS | -1.285 |
| Debt/Share | 0.3155 |
| Cash/Share | 7.23 |
| Book Value/Share | 11.56 |
| Tangible BV/Share | 11.56 |
| Equity/Share | 11.56 |
| Operating Cash Flow/Share | -0.804 |
| Capital Expenditure/Share | 0.027 |
| FCF/Share | -0.830 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.714 |
| Price/Fair Value | 2.99 |
| Debt/Market Cap | 0.0091 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -27.26 |